A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Recruiting · NCT06393738 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Lymphadenopathy, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, angioimmunoblastic T-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-09-04 | NCT06393738 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Arvinas Inc. | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||